Search

Your search keyword '"Wheeler, Vanessa"' showing total 345 results

Search Constraints

Start Over You searched for: Author "Wheeler, Vanessa" Remove constraint Author: "Wheeler, Vanessa"
345 results on '"Wheeler, Vanessa"'

Search Results

1. Splice modulators target PMS1 to reduce somatic expansion of the Huntington’s disease-associated CAG repeat

2. Contributors

4. CircHTT(2,3,4,5,6) — co-evolving with the HTT CAG-repeat tract — modulates Huntington's disease phenotypes

5. Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset

6. Genetic modifiers of Huntington disease differentially influence motor and cognitive domains

7. Correction to: Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat

8. Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat

9. Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington’s disease

10. Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport

11. Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington’s Disease

12. Somatic CAG Repeat Stability in a Transgenic Sheep Model of Huntington’s Disease

13. Modification of Huntington's disease by short tandem repeats

14. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset

16. Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington's disease.

17. CAG repeat expansion in the Huntington’s disease gene shapes linear and circular RNAs biogenesis

19. Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice.

23. Delineating regional vulnerability in the neurodegenerative disease SCA1 using a conditional mutant ATXN1 mouse

24. Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease

25. Franchising & Distribution Currents

27. Intangible Cruelty: The History, Risks, and Challenges of the Prejudgment Attachment of Intellectual Property and Its Implications for Franchisors.

29. D12 Faulty linear and back-splicing in Huntington’s disease: novel players in the pathologic process hint at innovative RNA biomarkers

30. A22 Medium-sized spiny neurons diversity in Huntington’s disease pathology

32. High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntingtonʼs disease CAG knock-in mice across multiple genetic backgrounds

33. LADR Case Notes (August 2022-October 2022) and FLJ Currents (Winter 2023).

36. Additional file 1 of Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat

37. Additional file 2 of Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat

38. Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.HttQ111/+ model of Huntington’s disease

39. Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat

40. Genetic modifiers of Huntington’s disease differentially influence motor and cognitive domains

41. Defective linear and circular RNAs biogenesis in Huntington’s disease: CAG repeat expansion hijacks neuronal splicing

44. Association Analysis of Chromosome X to Identify Genetic Modifiers of Huntington’s Disease

45. A04 Circhtt, a circular rna from the huntington’s disease gene locus: functional characterization and possible implications for disease modulation

46. FAN1, a DNA Repair Nuclease, as a Modifier of Repeat Expansion Disorders

47. Somatic CAG expansion in Huntington's disease is dependent on the MLH3 endonuclease domain, which can be excluded via splice redirection

48. Huntington’s Disease Pathogenesis: Two Sequential Components

49. Approaches to Sequence the HTT CAG Repeat Expansion and Quantify Repeat Length Variation

Catalog

Books, media, physical & digital resources